25 June 2025 A Correction to this paper has been published: References Mller TD, Finan B, Bloom SR, DAlessio D, Drucker DJ, Flatt PR, et al
Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound)
Initiating or maintaining Ozempic too early may increase complications such as delayed wound healing, increased infection risk, and diminished tissue repair
20 GeyikS.AltunskE.NeyalA
As stated in the rcgroups forum: "Testing reveals mAh is a variable governed by the Load Therefore the expression "A = Ah * C" can never be resolved unless the load is known
Patients interested in access should speak to their GP or consult the NIHR 'Be Part of Research' service to identify eligible clinical trials